Volcano Corporation
and Siemens Healthcare Announce Global Resale Agreement for Volcano
IVUS/FFR Systems
|
|
August 25, 2009 -- San Diego and Erlangen, Germany --
Volcano Corporation (Nasdaq: VOLC), a leader in the development,
manufacturing and sales of products for the diagnosis of coronary
and peripheral artery disease, announced today that it has entered
into a non-exclusive, global resale agreement with Siemens Healthcare,
a sector of Siemens AG (NYSE: SI). Under this agreement, Siemens
will resell Volcano-branded s5i IVUS/FFR systems and accessories
alongside Siemens' Artis family of X-ray systems.
The Volcano s5i intravascular ultrasound (IVUS) and fractional flow
reserve (FFR) system is compatible with Artis X-ray offerings. Volcano's
s5i is a component-based system that is incorporated directly into
the cath lab, allowing IVUS and FFR to be always on and always ready.
As a technology leader in the cath lab market, Siemens strives to
offer the most complete, state-of- the-art cath lab -- while focusing
on optimal work-flows. Volcano's s5i IVUS system is uniquely suited
to meet those needs, as it interacts seamlessly with the Siemens
x-ray systems.
Physicians are recognizing the value of IVUS and FFR as an integral
part of daily percutaneous coronary interventions. Volcano's IVUS
technology gives clinicians the ability to visualize vessel geometry,
understand plaque composition and make measurements for stent sizing.
Volcano's FFR technology allows physicians to make a physiological
measurement of a lesion to assess the requirement for treatment.
Volcano's s5i system uniquely integrates both technologies into the
cath lab on one system.
"IVUS and FFR usage is growing worldwide, and more and more
hospitals are seeking to include these technologies in their cath
lab design from the very beginning," commented Scott Huennekens,
president and chief executive officer of Volcano. "Our agreement
with Siemens Healthcare is yet another example of Volcano's commitment
to provide clinicians with market leading IVUS and FFR technology
that functions seamlessly with their X-ray equipment."
"With our Artis system, we bring the best in state-of-the-art
cath lab technology to the market." said Dr. Georg Nollert,
Global Marketing Manager Cardiology Systems. "Offering Volcano's
s5i IVUS / FFR system integrated into the Artis system supports our
goal of bringing best-in-class solutions to the interventional cardiologist."
The Volcano - Siemens resale agreement builds upon the established
compatibility between the Siemens Artis system and the Volcano s5i
integrated IVUS system previously demonstrated at the American College
of Cardiology (ACC) meetings.
About Volcano Corporation
Volcano Corporation (NASDAQ: VOLC) offers
a broad suite of devices designed to facilitate endovascular procedures,
enhance the diagnosis
of vascular and structural heart disease and guide optimal therapies.
The company's intravascular ultrasound (IVUS) product line includes
ultrasound consoles that can be integrated directly into virtually
any modern cath lab. Volcano IVUS offers unique features, including
both single-use phased array and rotational IVUS imaging catheters,
and advanced functionality options, such as VH(R) IVUS tissue characterization
and ChromaFlo(R). Volcano also provides functional measurement (FM)
consoles and single-use pressure and flow guide wires and is developing
a line of ultra-high resolution Optical Coherence Tomography (OCT)
and Forward-Looking IVUS systems and catheters. Currently, more than
4,400 Volcano IVUS and FM systems are installed worldwide, and more
than half of Volcano's revenues are derived from outside the United
States. Through its wholly-owned subsidiary, Axsun Technologies,
Volcano also develops and manufactures optical monitors, lasers and
optical engines used in telecommunications, spectroscopy and other
industrial applications. These products are sold to a variety of
customers, including Nokia Siemens, Ericsson, Alcatel-Lucent and
HuaWei Technologies. For more information, visit the company's website
at http://www.volcanocorp.com.
The Siemens Healthcare Sector is one of the world's largest suppliers
to the healthcare industry and a trendsetter in medical imaging,
laboratory diagnostics, medical information technology and hearing
aids. Siemens is the only company to offer customers products and
solutions for the entire range of patient care from a single source
- from prevention and early detection to diagnosis, and on to treatment
and aftercare. By optimizing clinical workflows for the most common
diseases, Siemens also makes healthcare faster, better and more cost-effective.
Siemens Healthcare employs some 49,000 employees worldwide and operates
in over 130 countries. In fiscal year 2008 (to September 30), the
Sector posted revenue of 11.2 billion euros and profit of 1.2 billion
euros. For further information please visit: www.siemens.com/healthcare.
Forward-Looking Statements
This press release contains forward-looking
statements within the meaning of the U.S. Private Securities Litigation
Reform Act of 1995.
Any statements in this release regarding Volcano's business that
are not historical facts may be considered "forward-looking
statements," including statements regarding the company's financial
guidance for 2009, market adoption of the company's technology, the
impact of clinical and other technical data, the timing and impact
of the company's transition to a direct sales force in Japan, including
impact on revenue, expenses and income, growth strategies, market
development and product sales. Forward-looking statements are based
on management's current preliminary expectations and are subject
to risks and uncertainties, which may cause Volcano's results to
differ materially and adversely from the statements contained herein.
Some of the potential risks and uncertainties that could cause actual
results to differ from the results predicted are detailed in the
company's annul report on Form 10-K, quarterly reports on Form 10-Q
and other filings made with the Securities and Exchange Commission.
Undue reliance should not be placed on forward-looking statements,
which speak only as of the date they are made. Volcano undertakes
no obligation to update any forward-looking statements to reflect
new information, events or circumstances after the date they are
made, or to reflect the occurrence of unanticipated events.
Source: Volcano
Corporation
|